Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

This publication has 22 references indexed in Scilit:

• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting
  New England Journal of Medicine, 1990
• Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial
  Cancer, 1987
• 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis
  Neuropharmacology, 1986
• Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other Sites
  British Journal of Urology, 1986
• Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.
  BMJ, 1984
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983
• Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy
  JAMA, 1982
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981
• The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order Effect
  Journal of the Royal Statistical Society Series C: Applied Statistics, 1981